Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$27.44 - $35.56 $104,738 - $135,732
3,817 Added 38.79%
13,658 $400,000
Q4 2023

Feb 14, 2024

BUY
$28.47 - $38.49 $280,173 - $378,780
9,841 New
9,841 $357,000
Q2 2023

Aug 14, 2023

SELL
$17.67 - $31.31 $780,960 - $1.38 Million
-44,197 Reduced 57.1%
33,210 $1.04 Million
Q1 2023

May 15, 2023

BUY
$17.13 - $38.52 $1.33 Million - $2.98 Million
77,407 New
77,407 $1.76 Million
Q2 2022

Aug 15, 2022

SELL
$33.25 - $45.11 $5,719 - $7,758
-172 Reduced 74.78%
58 $2,000
Q1 2022

May 16, 2022

SELL
$40.68 - $49.72 $35,717 - $43,654
-878 Reduced 79.24%
230 $10,000
Q4 2021

Feb 14, 2022

BUY
$43.21 - $57.6 $47,876 - $63,820
1,108 New
1,108 $53,000
Q3 2021

Nov 15, 2021

SELL
$52.8 - $60.32 $217,588 - $248,578
-4,121 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$51.29 - $59.15 $211,366 - $243,757
4,121 New
4,121 $224,000
Q4 2020

Feb 16, 2021

SELL
$35.18 - $43.52 $251,994 - $311,733
-7,163 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$37.98 - $48.72 $272,050 - $348,981
7,163 New
7,163 $279,000
Q1 2020

May 15, 2020

SELL
$22.46 - $42.24 $309,948 - $582,912
-13,800 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$39.01 - $47.51 $133,882 - $163,054
3,432 Added 33.1%
13,800 $572,000
Q3 2019

Nov 14, 2019

SELL
$38.66 - $47.41 $152,745 - $187,316
-3,951 Reduced 27.59%
10,368 $474,000
Q2 2019

Aug 14, 2019

BUY
$38.23 - $47.43 $58,033 - $71,998
1,518 Added 11.86%
14,319 $618,000
Q1 2019

May 15, 2019

BUY
$41.26 - $58.35 $101,664 - $143,774
2,464 Added 23.84%
12,801 $557,000
Q4 2018

Feb 14, 2019

BUY
$44.93 - $73.38 $287,596 - $469,705
6,401 Added 162.63%
10,337 $489,000
Q3 2018

Nov 14, 2018

BUY
$56.85 - $80.35 $223,761 - $316,257
3,936 New
3,936 $294,000

Others Institutions Holding SRDX

About SURMODICS INC


  • Ticker SRDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,005,000
  • Market Cap $477M
  • Description
  • Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...
More about SRDX
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.